Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Presenter: Susheel K. Kodali

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Presenter: Georg Nickenig

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Presenter: David H. Adams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Presenter: Steven F. Bolling

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

Presenter: Ted Feldman

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Advertisement

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content